Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Building the Future

Transforming your business model is difficult, but doable - here’s how

Bayer symbol

Bayer helps bankroll new stem cell company BlueRock

Start-up receives $225m to develop cardiovascular and neurodegenerative disease therapies

- PMLiVE

Medical device regulation – a risk-based approach to compliance

Medtechs will need to invest in upgrades to individual devices as well as broader business practices

- PMLiVE

Novartis’ AMD drug pegpleranib fails phase III programme

Plans for Lucentis-boosting duel-therapy stumble as trial data show no additional benefit

Publicis Health UK bolsters leadership team

Victoria Wright and Alister Sansum take on new roles

Biogen Idec building

Biogen rises on more positive data for Alzheimer’s candidate

Early-stage trial throws lifeline to proponents of beleaguered amyloid hypothesis

- PMLiVE

Gilead files hepatitis C salvage regimen in US

Seeks FDA approval for combination of Epclusa and voxilaprevir

- PMLiVE

Dr Colin Goddard appointed chairman at Mission Therapeutics

Will take up the role at the Cambridge, UK firm in January

- PMLiVE

Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role

He recently retired from Lilly after more than 15 years with the firm

- PMLiVE

2017: Medical education that improves value and outcomes for patients

In December’s Issue of PME, two of Lucid’s senior management team – Shula Sarner and Tanya Goodyear – consider how medical education will evolve in 2017.   They discuss industry...

Lucid Group Communications Limited

How can pharma engage with NHS Vanguards?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore the opportunities for pharma to help NHS vanguards develop new models of care.

Wilmington Healthcare

- PMLiVE

Plugging the Gaps

How technology can aid strategic workforce planning in pharma.

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links